Oncology Embolization Agents Market Snapshot

Published December 2023 | 10 Pages | 5 Exhibits | Forecasts Through 2027

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.

This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:

  • Unit volumes from 2022 to 2027
  • Market forecasts from 2022 to 2027
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

ABK Biomedical
Arsenal Medical
Boston Scientific
Cook
Cordis/Cardinal Health
Instylla
Medtronic
Merit Medical
Ned Medical
Obsidio
SirTex Medical
Stryker
Terumo
Varian

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.